Biomarin Pharmaceutical Inc number of employees

Biomarin Pharmaceutical Inc reported 3,221 employees at December 31, 2025 in its latest annual report, up 181 (6.0%) on the year before. That compares with 3,045 at December 31, 2021. Revenue per employee was $1.0m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	3,221	+181 (6.0%)	$1.0m	10-K, filed February 26, 2026
December 31, 2024	3,040	−361 (10.6%)	$938,788	10-K, filed February 24, 2025
December 31, 2023	3,401	+319 (10.4%)	$711,328	10-K, filed February 26, 2024
December 31, 2022	3,082	+37 (1.2%)	$680,091	10-K, filed February 27, 2023
December 31, 2021	3,045	—	$606,330	10-K, filed February 25, 2022

What the annual reports say

Human Capital As of December 31, 2025, we had 3,221 employees worldwide, of whom 1,518 were in operations, 692 were in research and development, 495 were in sales and marketing and 516 were in administration. 2025 annual report
Human Capital As of December 31, 2024, we had 3,040 employees worldwide, of whom 1,472 were in operations, 635 were in research and development, 458 were in sales and marketing and 475 were in administration. 2024 annual report
Human Capital As of December 31, 2023, we had 3,401 employees worldwide, of whom 1,509 were in operations, 807 were in research and development, 535 were in sales and marketing and 550 were in administration. 2023 annual report
Human Capital As of December 31, 2022, we had 3,082 full-time employees worldwide, of whom 1,343 were in operations, 736 were in research and development, 495 were in sales and marketing and 508 were in administration. 2022 annual report
Human Capital As of December 31, 2021, we had 3,045 full-time employees worldwide, of whom 1,336 were in operations, 692 were in research and development, 516 were in sales and marketing and 501 were in administration. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BMRN vs UTHR BMRN vs NBIX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biomarin Pharmaceutical Inc's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biomarin Pharmaceutical Inc.